Table 1.
Target new spine size | ||||||
---|---|---|---|---|---|---|
Groups | n value (spines/cells) | Pixel value/1,000 | Groups compared | p value | Test | |
Fig. 2 | CaMKIIα | 16/16 | 10 ± 1 | CaMKIIα vs CaMKIIα-K42R | 0.2 | Unpaired two-tailed t test |
CaMKIIα-K42R | 14/14 | 14 ± 2 | ||||
Fig. 4 | CaMKIIα-shRNA + CaMKIIα* | 18/18 | 13 ± 2 | CaMKIIα-shRNA + CaMKIIα* vs CaMKIIα-shRNA + mCaMKIIα* | 0.7 | One-way ANOVA with Tukey’s multiple comparisons |
CaMKIIα-shRNA + mCaMKIIα* | 10/10 | 16 ± 2 | ||||
CaMKIIα-shRNA | 20/20 | 21 ± 2 | CaMKIIα-shRNA vs CaMKIIα-shRNA + CaMKIIα* | 0.02 | ||
CaMKIIα-shRNA vs CaMKIIα-shRNA + mCaMKIIα* | 0.3 | |||||
Fig. 5 | GFP-CaMKIIα-T286D | 60/9 | 14 ± 2 | GFP-CaMKIIα-T286D vs GFP-CaMKIIα-T286D/K42R | 0.5 | |
GFP-CaMKIIα-T286D/K42R | 29/6 | 17 ± 3 | ||||
Control (dsRed-Express) | 51/9 | 13 ± 1 | Control vs GFP-CaMKIIα-T286D | 0.9 | ||
Control vs GFP-CaMKIIα-T286D/K42R | 0.3 | |||||
Target new spine length | ||||||
Groups | n value (spines/cells) | µm | Groups compared | p value | Test | |
Fig. 2 | CaMKIIα | 16/16 | 1.2 ± 0.2 | CaMKIIα vs CaMKIIα-K42R | 0.6 | Unpaired two-tailed t test |
CaMKIIα-K42R | 14/14 | 1.3 ± 0.2 | ||||
Fig. 4 | CaMKIIα-shRNA + CaMKIIα* | 18/18 | 1.2 ± 0.1 | CaMKIIα-shRNA + CaMKIIα* vs CaMKIIα-shRNA + mCaMKIIα* | 0.1 | One-way ANOVA with Tukey’s multiple comparisons |
CaMKIIα-shRNA + mCaMKIIα* | 10/10 | 0.8 ± 0.1 | ||||
CaMKIIα-shRNA | 20/20 | 1.1 ± 0.1 | CaMKIIα-shRNA vs CaMKIIα-shRNA + CaMKIIα* | 0.9 | ||
CaMKIIα-shRNA vs CaMKIIα-shRNA + mCaMKIIα* | 0.2 | |||||
Fig. 5 | GFP-CaMKIIα-T286D | 60/9 | 1.1 ± 0.1 | GFP-CaMKIIα-T286D vs GFP-CaMKIIα-T286D/K42R | 0.1 | |
GFP-CaMKIIα-T286D/K42R | 29/6 | 1.5 ± 0.2 | ||||
Control (dsRed-Express) | 51/9 | 1.3 ± 0.1 | Control vs GFP-CaMKIIα-T286D | 0.6 | ||
Control vs GFP-CaMKIIα-T286D/K42R | 0.3 | |||||
New spine outgrowth rate | ||||||
Groups | n value (spines/cells) | # spines/µm /60 min | Groups compared | p value | Test | |
Fig. 2 | CaMKIIα | 76/16 | 0.07 ± 0.01 | CaMKIIα vs CaMKIIα-K42R | 0.8 | Unpaired two-tailed t test |
CaMKIIα-K42R | 86/14 | 0.07 ± 0.01 | ||||
Fig. 4 | CaMKIIα-shRNA + CaMKIIα* | 104/18 | 0.07 ± 0.01 | CaMKIIα-shRNA + CaMKIIα* vs CaMKIIα-shRNA + mCaMKIIα* | 0.3 | One-Way ANOVA with Tukey’s multiple comparisons |
CaMKIIα-shRNA + mCaMKIIα* | 57/10 | 0.06 ± 0.01 | ||||
CaMKIIα-shRNA | 148/20 | 0.06 ± 0.01 | CaMKIIα-shRNA vs CaMKIIα-shRNA + CaMKIIα* | 0.8 | ||
CaMKIIα-shRNA vs CaMKIIα-shRNA + mCaMKIIα* | 0.6 | |||||
Fig. 5 | GFP-CaMKIIα-T286D | 60/9 | 0.06 ± 0.01 | GFP-CaMKIIα-T286D vs GFP-CaMKIIα-T286D/K42R | 0.5 | |
GFP-CaMKIIα-T286D/K42R | 29/6 | 0.05 ± 0.01 | ||||
Control (dsRed-Express) | 51/9 | 0.05 ± 0.01 | Control vs GFP-CaMKIIα-T286D | 0.7 | ||
Control vs GFP-CaMKIIα-T286D/K42R | 0.9 |
The morphological characteristics of target new spines and outgrowth rates are compared at the time of first appearance (at the end of the first 60 min time-lapse interval).